HealthUnlocked

Redirect Notice

Looks like you clickedhttp://globenewswire.com/news-release/2015/10/06/773620/10151755/en/INNATE-PHARMA-OPENING-OF-THE-PHASE-I-II-TRIAL-OF-IPH2201-IN-COMBINATION-WITH-IBRUTINIB-IN-PATIENTS-WITH-RELAPSED-OR-REFRACTORY-CHRONIC-LYMPHOCYTIC-LEUKEMIA.html

If you do not want to visit that page, you can close this browser tab.